Tilray Stock: Risky Growth Stock or Value Pick?

Is Tilray stock a reasonable bet long-term investors should think about making right now, or is this stock too risky to buy right now?

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The cannabis sector is a fast-growing one, expected to see worldwide sales really $176 billion by 2030. For investors in Tilray (TSX:TLRY)(NASDAQ:TLRY) stock, this growth has been the key investment thesis for some time.

However, actual growth rates in Canada for marijuana sales have underperformed of late. Previous excesses in the valuation of cannabis stocks have led to quite the downturn for Tilray. Today, Tilray stock trades at a small fraction of its previous high, down well more than 90% from its peak.

Will growth investors return to the cannabis sector? And if so, will Tilray stock be one investors pick? Let’s dive in.

Tilray posts positive net income, pushing for more market share

Well, there’s some good news for investors look at Tilray stock from a fundamentals standpoint.

Earlier this month, Tilray announced its earnings. The company posted a net income of roughly US$6 million in its latest quarter in comparison with a net loss of approximately US$89 million in the same quarter in 2021. The organization stated that its net income for the quarter that ended on November 30 broke even on a per-share basis. As a reference, the same quarter of 2021 saw a loss of $0.41 per share.

These solid numbers did boost Tilray stock 15% immediately following these results. However, since the earnings report, Tilray has seen selling, as recent macro headwinds hit growth stocks hard. The potential for rising interest rates has investors in more speculative areas cautious, leading to valuation compression among companies like Tilray.

That said, investors looking for growth may like Tiray’s push into the hemp market and CBD-infused beverage market. Clearly a risky pick, Tilray stock is one that has inspired near-term rallies some retail investors may be enamoured by.

More positives for Tilray stock

Investors should also remember that Tilray has made some acquisitions to broaden its portfolio. The company recently bought SweetWater Brewing and Breckenridge Distillery to deliver growth in the beverage category. Also, Tilray purchased Manitoba Harvest to drive its market share in consumer packaged goods.

To reflect its transition from a Canada based licensed cannabis producer to a global consumer packaged goods organization, Tilray has planned to use Tilray Brands Inc. as its new parent brand name.

Tilray Brands is looking forward to growing its presence in the United States and internationally. Along with all its growth opportunities, the company anticipates producing annual revenue of $4 billion by fiscal 2024. Now that’s a substantial jump! 

Bottom line

The reality is that the market is taking a risk-off approach right now. Tilray, once a meme stock (before the term was “cool” by WallStreetBets standards), has seen its share of surges in the past. However, shifting investor sentiment away from growth and toward value could hamper this stock in the near term.

That said, these recent results are a positive. Perhaps Tilray stock is a decent pickup at these levels. Time will tell.

For now, I remain on the sidelines with respect to Tilray due to its risk profile.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »